Correction: Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373671/
https://www.ncbi.nlm.nih.gov/pubmed/37487668
http://dx.doi.org/10.1136/jitc-2023-006871corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373671/
https://www.ncbi.nlm.nih.gov/pubmed/37487668
http://dx.doi.org/10.1136/jitc-2023-006871corr1

Ejemplares similares